Compare WDFC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WDFC | INSP |
|---|---|---|
| Founded | 1953 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 1995 | 2018 |
| Metric | WDFC | INSP |
|---|---|---|
| Price | $221.24 | $68.27 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 18 |
| Target Price | ★ $254.00 | $68.00 |
| AVG Volume (30 Days) | 124.4K | ★ 610.3K |
| Earning Date | 10-21-2026 | 11-02-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ 6.08 | N/A |
| Revenue | ★ $488,109,000.00 | $82,050,000.00 |
| Revenue This Year | $5.80 | N/A |
| Revenue Next Year | $5.23 | $3.90 |
| P/E Ratio | $36.34 | ★ N/A |
| Revenue Growth | 19.49 | ★ 62.18 |
| 52 Week Low | $175.38 | $38.91 |
| 52 Week High | $298.90 | $147.03 |
| Indicator | WDFC | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 63.81 | 45.49 |
| Support Level | $219.00 | $67.10 |
| Resistance Level | $226.33 | $73.69 |
| Average True Range (ATR) | 6.49 | 2.50 |
| MACD | 2.22 | -0.27 |
| Stochastic Oscillator | 91.79 | 13.27 |
WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.